Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003220334 | SCV003914080 | uncertain significance | Inborn genetic diseases | 2023-03-02 | criteria provided, single submitter | clinical testing | The c.4375G>T (p.D1459Y) alteration is located in exon 31 (coding exon 29) of the IFT140 gene. This alteration results from a G to T substitution at nucleotide position 4375, causing the aspartic acid (D) at amino acid position 1459 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005012808 | SCV005642685 | uncertain significance | Saldino-Mainzer syndrome; Retinitis pigmentosa 80 | 2024-06-05 | criteria provided, single submitter | clinical testing |